These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 25960299)

  • 1. Calciphylaxis: risk factors, diagnosis, and treatment.
    Nigwekar SU; Kroshinsky D; Nazarian RM; Goverman J; Malhotra R; Jackson VA; Kamdar MM; Steele DJ; Thadhani RI
    Am J Kidney Dis; 2015 Jul; 66(1):133-46. PubMed ID: 25960299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calciphylaxis treated with sodium thiosulfate: report of two cases.
    Garcia CP; Roson E; Peon G; Abalde MT; De La Torre C
    Dermatol Online J; 2013 Sep; 19(9):19616. PubMed ID: 24050290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calciphylaxis in a renal transplant recipient with normal graft function: A case report and review of literature.
    Kale G; Jeloka T; Shrividya S; Mulay A; Deshmukh M; Krishnan S; Nigwekar S
    Saudi J Kidney Dis Transpl; 2019; 30(1):215-220. PubMed ID: 30804284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
    Meissner M; Gille J; Kaufmann R
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1037-44. PubMed ID: 17176411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcific uremic arteriolopathy in hemodialyzed patients.
    Checheriţă IA; Smarandache D; Rădulescu D; Peride I; Bratu O; Ciocâlteu A; Sebe I; Lascăr I
    Chirurgia (Bucur); 2013; 108(5):736-40. PubMed ID: 24157123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcific uremic arteriolopathy - treatment with sodium thiosulfate].
    Vyskočilová M; Svojanovský J; Blaštíková J; Dvořáková G; Souček M
    Vnitr Lek; 2015 Feb; 61(2):166-72. PubMed ID: 25813263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy.
    Santos PW; He J; Tuffaha A; Wetmore JB
    Int Urol Nephrol; 2017 Dec; 49(12):2247-2256. PubMed ID: 29058165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calciphylaxis: an uncertain pathogenesis and controversial treatment].
    Marrón B; Coronel F; López-Bran E; Barrientos A
    Nefrologia; 2001; 21(6):596-600. PubMed ID: 11881431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcific uremic arteriolopathy: a call for action.
    Brandenburg VM; Cozzolino M; Mazzaferro S
    Semin Nephrol; 2014 Nov; 34(6):641-7. PubMed ID: 25498382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calciphylaxis, a diagnostic and therapeutic challenge: report of a successful case.
    Roncada EV; Abreu MA; Pereira MF; Oliveira CC; Nai GA; Soares DF
    An Bras Dermatol; 2012; 87(5):752-5. PubMed ID: 23044570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary approach to calcific uremic arteriolopathy.
    Nigwekar SU
    Curr Opin Nephrol Hypertens; 2015 Nov; 24(6):531-7. PubMed ID: 26371529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series.
    Sood AR; Wazny LD; Raymond CB; Leung K; Komenda P; Reslerova M; Verrelli M; Rigatto C; Sood MM
    Clin Nephrol; 2011 Jan; 75(1):8-15. PubMed ID: 21176746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcific uremic arteriolopathy while on cinacalcet.
    Gonzalez-Parra E; Martin-Cleary C; Martin J; Ortiz A
    J Postgrad Med; 2011; 57(1):51-2. PubMed ID: 21206121
    [No Abstract]   [Full Text] [Related]  

  • 14. An Update on Calciphylaxis.
    García-Lozano JA; Ocampo-Candiani J; Martínez-Cabriales SA; Garza-Rodríguez V
    Am J Clin Dermatol; 2018 Aug; 19(4):599-608. PubMed ID: 29808451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questionable specificity of histologic findings in calcific uremic arteriolopathy.
    Ellis CL; O'Neill WC
    Kidney Int; 2018 Aug; 94(2):390-395. PubMed ID: 29885932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calciphylaxis: an enigma to the nephrologist].
    Barbera V; Di Lullo L; Otranto G; Barbera G; Santoboni A
    G Ital Nefrol; 2012; 29(6):674-82. PubMed ID: 23229665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calciphylaxis: Controversies in Pathogenesis, Diagnosis and Treatment.
    Jeong HS; Dominguez AR
    Am J Med Sci; 2016 Feb; 351(2):217-27. PubMed ID: 26897281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
    Gaisne R; Péré M; Menoyo V; Hourmant M; Larmet-Burgeot D
    BMC Nephrol; 2020 Feb; 21(1):63. PubMed ID: 32101140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcific uremic arteriolopathy: clinical features and treatment].
    Kudumija B; Knotek M; Pavlović D; Dits S
    Lijec Vjesn; 2015; 137(3-4):91-5. PubMed ID: 26065286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciphylaxis mimicking skin lesions of connective tissue diseases.
    Lue C; Boulware DW; Sanders PW; Omura EF; Ball EV
    South Med J; 1996 Nov; 89(11):1099-100. PubMed ID: 8903297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.